ArticleJournal of thoracic disease2025
Survey of physicians' approaches to the clinical evaluation of interstitial lung disease in Singapore (SoPhoCLES).
Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Clinical Utility of an FDA-Authorized Artificial Intelligence Imaging Platform in Interstitial Lung Disease Diagnosis.Diagnostics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The diagnostic gold standard for interstitial lung disease (ILD) has evolved from histopathology to multidisciplinary discussion (MDD) consensus. However, physicians' practices remain heterogeneous, impacting upon core data acquisition, interpretation and eventual MDD diagnosis. Our study compared approaches between ILD (fellowship-trained and providing dedicated ILD services) and non-ILD physicians in Singapore. Methods: Between October 2017 and January 2018, non-ILD respiratory physicians from public hospitals in Singapore were invited to participate in a survey designed by a focus group comprising ILD and non-ILD physicians. Responses of local ILD physicians were benchmarked against that of overseas ILD physicians from expert centres and thoracic radiologists. Results: Fifty-nine of ninety-six (61%) local physicians responded. As practices between local and overseas ILD physicians revealed no significant differences, they were pooled together for analysis. ILD physicians diagnosed more cases annually, presented more frequently at MDD, utilised supportive tests more consistently, reported higher confidence levels interpreting high resolution computed tomography (HRCT) and placed higher weightage on physician rather than radiologist or pathologist opinion. In four case-based scenarios, there were higher levels of agreement in diagnoses among ILD than non-ILD physicians. Inter-rater agreement on radiological diagnoses was moderate among ILD physicians (κ=0.55) and between ILD physicians and radiologists (κ=0.56), but fair among non-ILD physicians (κ=0.29) and both physician groups (κ=0.25). Inter-rater agreement on clinical diagnoses was moderate among ILD physicians (κ=0.52), but fair among non-ILD physicians (κ=0.35). Conclusions: Substantial differences between ILD physicians and non-ILD physicians exist. Early referral to appropriate expertise is recommended.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.